Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 4490 | 1703 | 27.6 | 69% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 77 | 26633 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//NUCLEOSIDES & NUCLEOTIDES//NUCLEOSIDES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ACYCLIC NUCLEOSIDE PHOSPHONATES | Author keyword | 56 | 64% | 3% | 55 |
| 2 | ACYCLIC NUCLEOSIDE PHOSPHONATE | Author keyword | 32 | 85% | 1% | 17 |
| 3 | PMEA | Author keyword | 25 | 58% | 2% | 28 |
| 4 | PMEDAP | Author keyword | 23 | 100% | 1% | 10 |
| 5 | PMEG | Author keyword | 23 | 100% | 1% | 10 |
| 6 | ACYCLIC NUCLEOTIDE ANALOGUES | Author keyword | 23 | 72% | 1% | 18 |
| 7 | ALKYLATION ELIMINATION | Author keyword | 20 | 100% | 1% | 9 |
| 8 | HPMPA | Author keyword | 18 | 83% | 1% | 10 |
| 9 | POLYMETHYLENE ANALOGUES | Author keyword | 17 | 100% | 0% | 8 |
| 10 | CIDOFOVIR | Author keyword | 15 | 18% | 5% | 78 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ACYCLIC NUCLEOSIDE PHOSPHONATES | 56 | 64% | 3% | 55 | Search ACYCLIC+NUCLEOSIDE+PHOSPHONATES | Search ACYCLIC+NUCLEOSIDE+PHOSPHONATES |
| 2 | ACYCLIC NUCLEOSIDE PHOSPHONATE | 32 | 85% | 1% | 17 | Search ACYCLIC+NUCLEOSIDE+PHOSPHONATE | Search ACYCLIC+NUCLEOSIDE+PHOSPHONATE |
| 3 | PMEA | 25 | 58% | 2% | 28 | Search PMEA | Search PMEA |
| 4 | PMEDAP | 23 | 100% | 1% | 10 | Search PMEDAP | Search PMEDAP |
| 5 | PMEG | 23 | 100% | 1% | 10 | Search PMEG | Search PMEG |
| 6 | ACYCLIC NUCLEOTIDE ANALOGUES | 23 | 72% | 1% | 18 | Search ACYCLIC+NUCLEOTIDE+ANALOGUES | Search ACYCLIC+NUCLEOTIDE+ANALOGUES |
| 7 | ALKYLATION ELIMINATION | 20 | 100% | 1% | 9 | Search ALKYLATION+ELIMINATION | Search ALKYLATION+ELIMINATION |
| 8 | HPMPA | 18 | 83% | 1% | 10 | Search HPMPA | Search HPMPA |
| 9 | POLYMETHYLENE ANALOGUES | 17 | 100% | 0% | 8 | Search POLYMETHYLENE+ANALOGUES | Search POLYMETHYLENE+ANALOGUES |
| 10 | CIDOFOVIR | 15 | 18% | 5% | 78 | Search CIDOFOVIR | Search CIDOFOVIR |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ACYCLIC NUCLEOTIDE ANALOGS | 73 | 73% | 3% | 56 |
| 2 | ACYCLIC NUCLEOSIDE PHOSPHONATES | 65 | 46% | 6% | 107 |
| 3 | NUCLEOTIDE ANALOGS | 58 | 37% | 7% | 125 |
| 4 | 9 2 PHOSPHONYLMETHOXYETHYLADENINE | 56 | 58% | 4% | 65 |
| 5 | ANTIRETROVIRUS ACTIVITY | 53 | 79% | 2% | 34 |
| 6 | ANTI DNA VIRUS | 38 | 64% | 2% | 37 |
| 7 | S 1 3 HYDROXY 2 PHOSPHONYLMETHOXYPROPYLCYTOSINE | 36 | 49% | 3% | 54 |
| 8 | PMEA | 36 | 54% | 3% | 46 |
| 9 | 9 2 PHOSPHONYLMETHOXYETHYLADENINE PMEA | 28 | 68% | 1% | 25 |
| 10 | PHOSPHONYLMETHOXYALKYL DERIVATIVES | 26 | 57% | 2% | 31 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Acyclic nucleoside phosphonates: A key class of antiviral drugs | 2005 | 286 | 124 | 52% |
| Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir | 1999 | 177 | 40 | 75% |
| Highlights in the Discovery of Antiviral Drugs: A Personal Retrospective | 2010 | 53 | 94 | 41% |
| The acyclic nucleoside phosphonates from inception to clinical use: Historical perspective | 2007 | 71 | 104 | 62% |
| Phosphonomethoxyalkyl analogs of nucleotides | 2003 | 151 | 336 | 64% |
| Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base | 1999 | 106 | 104 | 80% |
| A 40-Year Journey in Search of Selective Antiviral Chemotherapy | 2011 | 44 | 116 | 34% |
| The Acyclic Nucleoside Phosphonates (ANPs): Antonin Holy's Legacy | 2013 | 8 | 84 | 60% |
| HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: A review of their pharmacology and clinical potential in the treatment of viral infections | 1997 | 170 | 129 | 69% |
| Antiviral acyclic nucleoside phosphonates structure activity studies | 2006 | 32 | 18 | 89% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BK PROJECT TEAM 21 | 14 | 65% | 0.8% | 13 |
| 2 | CHEMEXPT CLIN CHEMOTHER Y PROGRAM | 14 | 100% | 0.4% | 7 |
| 3 | CHEMDEV THER EUT PROGRAM | 9 | 83% | 0.3% | 5 |
| 4 | MED 0676 | 9 | 83% | 0.3% | 5 |
| 5 | SAN DIEGO VET MED FDN | 3 | 100% | 0.2% | 3 |
| 6 | PROJECT TEAM BK 21 | 3 | 37% | 0.4% | 7 |
| 7 | CHIM PHYS ORGAN | 3 | 30% | 0.4% | 7 |
| 8 | NOVEL ANTIVIRALS ANTINEOPLAST | 2 | 44% | 0.2% | 4 |
| 9 | CHEMBARBARA ANN KARMANOS CANC | 2 | 67% | 0.1% | 2 |
| 10 | INSERM U544 | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000148782 | OXETANOCIN A//CARBOCYCLIC OXETANOCIN//UP A CNRS 6011 |
| 2 | 0.0000119889 | PRONUCLEOTIDES//PROTIDE//PRONUCLEOTIDE |
| 3 | 0.0000116162 | ACYCLOVIR RESISTANCE//ASP2151//BAY 57 1293 |
| 4 | 0.0000112242 | ISONUCLEOSIDE//ISONUCLEOSIDES//AZT ANALOGS |
| 5 | 0.0000099591 | TRIAZOLE NUCLEOSIDES//COMBINATORIAL CHEM DRUG DISCOVERY//GILEAD SCI IOCB |
| 6 | 0.0000098375 | CARBOCYCLIC NUCLEOSIDES//S ADENOSYLHOMOCYSTEINE HYDROLASE//CARBOCYCLIC NUCLEOSIDE |
| 7 | 0.0000096447 | BV ARAU//5 ETHYL 2 DEOXYURIDINE//BCNA |
| 8 | 0.0000091303 | KETONUCLEOSIDES//UNSATURATED NUCLEOSIDES//EXOMETHYLENE NUCLEOSIDES |
| 9 | 0.0000078466 | AGELASINE//PL BIOL SAKYO KU//ASMARINE |
| 10 | 0.0000064008 | ACYCLOVIR//9 CARBOXYMETHOXYMETHYLGUANINE//VALACYCLOVIR |